Eric Lev

Eric Lev is a prominent figure in the healthcare investment sector, currently serving as a General Partner at Ampersand Capital Partners and as a Board Member at iuvo BioScience. He has over 20 years of experience in middle-market healthcare investments, having joined Ampersand in 2013.

Education and Career

• Education: Eric holds a B.A. in Economics from Northwestern University and an M.B.A. from the University of Chicago.
• Previous Experience: Before joining Ampersand, he was part of the investment team at Water Street Healthcare Partners for seven years and has also worked at Beckman Coulter and One Equity Partners.

Board Memberships

Eric Lev's extensive board experience includes positions at several companies:

• Current Board Seats: iuvo BioScience, LakePharma, Nexelis, and Leinco Technologies.
• Past Board Seats: ALPCO, Biologos, Biosynth, CutisPharma, Genoptix, and others.123

Contributions to iuvo BioScience

At iuvo BioScience, Eric's role involves guiding strategic decisions and overseeing the company's growth within the biopharmaceutical sector. His expertise in investments and healthcare operations significantly contributes to the company's objectives in drug development and clinical research.23